ArticleChina CDC weekly2025
Vaccination Status and Incidences of Measles, Mumps, and Rubella - Worldwide, 2014-2023.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Comparative long-term follow-up study of persistence of immunity after JVC-001 measles, mumps, and rubella vaccination in Japanese children.Human vaccines & immunotherapeutics · 2025Trial
- Bridging the Gap: Measles Susceptibility and Neutralization Test-Confirmed Immunity in a Spanish HIV-PrEP Cohort.Open forum infectious diseases · 2026Article
- Spatio-Temporal Modelling and Forecasting of the Prolonged Measles Outbreak in Romania: Insights and Challenges.Healthcare (Basel, Switzerland) · 2025Article
- Impact of vaccination strategy adjustments on antibody levels against measles, rubella, mumps, and varicella in China: a single-center serological survey.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Measles, mumps, and rubella remain significant global health threats despite being vaccine-preventable diseases. The World Health Organization aims to achieve regional elimination of measles and rubella by 2030, yet substantial disparities in vaccination coverage and disease incidence persist across regions. We analyzed global vaccination and disease data to provide evidence for optimizing immunization strategies. Methods: The study analyzed World Health Organization data on measles, mumps, and rubella from 2014-2023. Our analysis included vaccine types, recommended vaccination schedules, coverage rates, supplemental immunization activities, and disease incidence. We employed descriptive epidemiological methods for data synthesis and analysis. Results: All countries implemented ≥1 measles-containing vaccine dose, with 190 (97.9%) countries using a ≥2-dose schedule. Global 2nd dose of measles-containing vaccine coverage increased from 59% to 74% during the study period. High-income regions maintained >90% coverage, while the African Region reported the lowest coverage (70% for the 1st dose and 49% for the 2nd dose of measles-containing vaccine). Supplemental immunization activities helped address coverage gaps but required integration with routine immunization systems. Rubella vaccine was implemented in 90.2% of countries, while mumps vaccine adoption remained lower at 63.9%. The African Region experienced high incidence rates for both measles (551.8 per million) and rubella (21.9 per million). The COVID-19 pandemic disrupted vaccination coverage (3%-5% decline globally), with the African Region experiencing a post-pandemic U-shaped resurgence in cases. China's transition to the measles, mumps, and rubella vaccine has reduced mumps incidence to below 100 cases per million by 2020. Conclusions: While global control of measles, mumps, and rubella has progressed, inequities in vaccination coverage and pandemic-related disruptions threaten elimination goals. Strengthening routine immunization systems is critical. Achieving the World Health Organization's 2030 targets will require sustained investment in health systems and implementation of equity-focused innovations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.